Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBO-BOOST: Ervebo and Zabdeno Boosters in DRC
NCT06126822Phase 3Recruiting
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Feb 2025
- Primary completion
- Oct 2026
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Ebola Zaire vaccine (live, attenuated), zabdeno in Ebola virus disease (EVD), sponsored by Institute of Tropical Medicine Antwerp. Started Feb 2025; status: recruiting.
02
Drugs
Ebola Zaire vaccine (live, attenuated)zabdeno
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT06126822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06126822.